Navigation Links
Drug Advertising needs to be Limited

The American Medical Association has called for moratoriums on consumer advertising which promotes new drugs and medical devices until it is shown that the products// are safe and that they work.

The American Medical Association, U.S. largest physicians' group has urged the U.S. Food and Drug Administration to instruct manufacturers to complete an unspecified waiting period after a drug or device obtains regulatory approval before direct-to-consumer advertising is launched on television, in print, or elsewhere.

Although the doctors' groups have considered a years-long moratorium, they decided to let the FDA set the time span, depending on whether the drug or device breaks new ground.

According to physicians several patients demand inappropriate drugs after being exposed to a drug company's advertisement. Drug makers have said the ads educate the public and only advise patients to ask their doctors.

The house of delegates of the AMA which set the group's policy at its annual meeting has recommended that the FDA pre-approve such advertisements, ensuring that they are based on objective information from clinical trials that would reveal the balance between a product's benefits and risks, as well as define warnings and potential adverse reactions properly.

The AMA's president-elect, Dr. Ronald Davis said, 'Physicians will have the opportunity to become better educated on the pros and cons of prescription drug uses before prescribing them, and will be better able to determine when they are best suited for their patients' medical needs.'

A drug industry group has said that it shared the AMA's goal of educating the public which was proved by last year's agreement among manufacturers to voluntarily inform the health-care community before launching consumer ads.

Dr. Paul Antony of the Pharmaceutical Research and Manufacturers of America said, 'The length of time this requires will vary from medicine to medicine, and companies will likely meet this goal in different ways.'

High-profile drugs like Vioxx was withdrawn by Merck in 2004 following the development of problematic side affects like an increase in heart attacks and strokes. Vioxx was popularized because of its huge advertising budget.

AMA' s decision came following argument by some plaintiffs in lawsuits that Merck continued to promote the painkiller despite knowledge that it carried risks.


'"/>




Related medicine news :

1. Anti-tobacco Advertising Can Reduces smoking Among Teens
2. New Rule Results In The Complete Makeover In The Field Of Drug Advertising
3. Subliminal Advertising works
4. Pfizer Commences Its Advertising for Celebrex with All the Warnings
5. Tobacco Advertising Through Movies Luring Kids
6. Advertising Blamed For Kids Poor Choices
7. CDC Uses Advertising Campaign to Get Kids Moving
8. Synova Acquires Rights to Today Sponge Contraceptive, Plans Advertising Campaign
9. Body mass index guide needs revision
10. Risk of heart disease prediction needs updating
11. Air pollution combined with greater medical needs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... Fla. (PRWEB) , ... October 12, 2017 , ... IsoComforter, ... therapy products, announced today the introduction of an innovative new design of the shoulder ... pad so you get maximum comfort while controlling your pain while using cold therapy. ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally ... care, have expanded their existing home health joint venture through an agreement, effective ... operating a joint venture home health company with Asante, delivering clinically integrated care, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, the Los ... article to the newly revamped Cosmetic Town journal section, featuring articles ... procedure known as Follicular Unit Extraction (FUE). , Dr. Mohebi says ...
(Date:10/12/2017)... ... ... Leading pediatric oncology experts at Children’s National Health System will ... the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by Jeffrey ... Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief of the Division ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and ... 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness will ... Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry Autograph ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017 Diplomat Pharmacy, Inc. ... Day Software and Consulting, LLC , and named its ... Software, based in Tennessee , will ... Day expands EnvoyHealth,s service offerings for health care partners ... "In an interoperable world, ...
(Date:10/2/2017)... 2017 Halo Labs announces the European launch of their ... HORIZON at MIBio 2017 in Cambridge, U.K ... matter in biopharmaceutical samples with unprecedented speed and sensitivity while using ... Backgrounded Membrane Imaging. ... subvisible particle analysis system ...
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation announce a ... sensors for real-time monitoring of patients with trauma-related and ... focused on disruptive health solutions for rare disorders and ... record and integrate behavioral, cognitive, physiological and contextual data. ... ...
Breaking Medicine Technology: